NCT01841437

Brief Summary

The purpose of this study is to observe the safety of the Glaukos® iStent® Trabecular Micro-Bypass Stent Model GTS100 in conjunction with cataract surgery in subjects with mild to moderate open-angle glaucoma.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
191

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2013

Typical duration for all trials

Geographic Reach
1 country

18 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 24, 2013

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 26, 2013

Completed
4 months until next milestone

Study Start

First participant enrolled

September 1, 2013

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 16, 2016

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 21, 2016

Completed
Last Updated

December 18, 2017

Status Verified

August 1, 2017

Enrollment Period

2.5 years

First QC Date

April 24, 2013

Last Update Submit

December 14, 2017

Conditions

Keywords

Primary open-angle glaucoma (POAG)Trabecular meshworkiStent

Outcome Measures

Primary Outcomes (1)

  • Rate of sight-threatening adverse events

    36 months

Secondary Outcomes (1)

  • Other ocular adverse events

    36 months

Study Arms (1)

iStent

Device: iStent

Interventions

iStentDEVICE
iStent

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Consecutive subjects in whom implantation of the iStent is attempted at selected clinical sites

You may qualify if:

  • Consecutive subjects in whom implantation of the iStent is attempted

You may not qualify if:

  • Please refer to approved indications in Directions for Use

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (18)

Unknown Facility

Chico, California, 95926, United States

Location

Unknown Facility

Huntington Beach, California, 92647, United States

Location

Unknown Facility

Napa, California, 94558, United States

Location

Unknown Facility

Santa Maria, California, 93454, United States

Location

Unknown Facility

Ventura, California, 93003, United States

Location

Unknown Facility

Parker, Colorado, 80134, United States

Location

Unknown Facility

Portland, Maine, 04102, United States

Location

Unknown Facility

Quincy, Massachusetts, 02169, United States

Location

Unknown Facility

Bloomington, Minnesota, 55431, United States

Location

Unknown Facility

Westwood, New Jersey, 07675, United States

Location

Unknown Facility

Durham, North Carolina, 27710, United States

Location

Unknown Facility

Fayetteville, North Carolina, 28304, United States

Location

Unknown Facility

Southern Pines, North Carolina, 28387, United States

Location

Unknown Facility

Brecksville, Ohio, 44141, United States

Location

Unknown Facility

Youngstown, Ohio, 44502, United States

Location

Unknown Facility

Ladson, South Carolina, 29456, United States

Location

Unknown Facility

Sioux Falls, South Dakota, 57108, United States

Location

Unknown Facility

Appleton, Wisconsin, 54914, United States

Location

MeSH Terms

Conditions

Glaucoma, Open-Angle

Condition Hierarchy (Ancestors)

GlaucomaOcular HypertensionEye Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
36 Months
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 24, 2013

First Posted

April 26, 2013

Study Start

September 1, 2013

Primary Completion

February 16, 2016

Study Completion

June 21, 2016

Last Updated

December 18, 2017

Record last verified: 2017-08

Locations